In an adult healthy volunteer population in Bogota, Colombia, using orbital US we obtained a mean ONSD-TP of 3.96 mm (95% CI: 3.85 mm-4.07 mm) and a mean ONSD-TP of 4.0 mm (95% CI: 3.90 mm-4.11 mm). The range ONSD-TP and ONSD-SP were 2.35 mm to 5.15 mm and from 2.60 mm to 5.20 mm, respectively. We found a strong correlation between ONSD-TP and ONSD-SP (p < 0.0001), intraclass correlation between eyes was statistically significant and comparable with previous reports(9). We did not find any statistical association between age, sex, BMI, HC and US measures of ONSD (p > 0.05), as have been showed in a recent systematic review and metanalysis (8). None of ONSD in either plane in this healthy adult population was greater than 5.2 mm.
Previous studies of US ONSD measures in healthy population (children and adults) are in the range of 2.2 to 5.4 mm. In 67 subjects in United Kingdom the range was 2.4–4.7 mm (mean 3.2–3.6 mm) in 26 subjects in Greece was 2.2–4.9 mm (mean 3.6 mm) and in 136 subjects in Bangladesh was 4.24–4.83 mm (mean 4.41 mm) (10). Higher values of US ONSD have been found in studies in Iran, (range 3.8–5.4 mm, mean 4.6 mm) China (range 4.7–5.4 mm, mean 5.1 mm) and Korea (range 4.6–5.2 mm, mean 4.9 mm) (5). US cut-off values of ONSD for diagnosis of increased ICP have ranged from 4.1 to 5.7 mm with a good correlation with invasive measures. Cut-off measures of US ONSD of 4.7 to 5.7 mm for increased ICP show a sensitivity of 70–100% and specificity of 31.9–100% (11).
US ONSD measures have shown minimal inter-observer and eye to eye variations. Inter-observer variation is +/-0.2-0.3 mm and differences in measures between the axial and sagittal plane of US ONSD are in the range of 0-0.3 mm (mean 0.15 mm)(12). The learning curve for performing an optimal orbital US ONSD measure is between 10 to 25 scans(13). According to the studies mentioned above ONSD in US does not vary in relation to age, weight, and height. A study including HC, did not find a relation between ONSD and HC (14). But ONSD may vary in relation to sex and ethnicity (7).
Although, studies have reported on many parameters of US ONSD in healthy populations, no world consensus exists on normal US ONSD measures and cut-off values for diagnosis of ICP (15). Knowledge of the normal range of US ONSD in healthy local population is essential to interpret the results. Based on the results of our study, previous research and expected deviations when measuring US ONSD, we proposed normal values in Colombian healthy adults of 2.35–5.20 mm and cut-off value for diagnosing increased ICP of 5.5 mm.
The study has strengths and limitations. To the best of our knowledge, this is the first study with exclusively a Latin-American subjects (8). Relationships between demographic (age, gender) and anthropometric (weight, height, BMI, and HC) variables with US ONSD were analyzed. The sample size is robust and there was careful exclusion of subjects with potential pathologic ONSD. Subjects were examined in a systematic and standardised fashion by trained physicians.
This study has some limitations. The mean age of our patient was 26.7 ± 8.3 years; and some authors have suggested the possible influence of ageing and brain atrophy on ONSD. However, previous studies have shown that ONSD remains similar during adult life and do not vary even in healthy adults aged 65 years or older(16). Second, the inter-observer variability was not analyzed as investigators measured ONSD in different volunteers. A direct measurement of ICP was not performed, and how the upper values of US ONSD correlate with ICP could not be determined. Also, for comparisons measurement of ONSD through other non-invasive method were not carried out. Finally, the lack of studies in healthy adult Latin-American populations limit out possibility for comparison. Despite the limitations mentioned and the knowledge that further research is needed for on the US ONSD and its correlation to increased ICP; our study should be perceived in the building of normative data for Latin-American US laboratories.